Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
Article in Clinical Cancer Research (April 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Article in Journal of Translational Medicine (February 2024)
Promises and Limitations of Current Models for Understanding Barrett’s Esophagus and Esophageal Adenocarcinoma
Article in Cellular and Molecular Gastroenterology and Hepatology (February 2024)